Chrysalis Holdings acquired Azzur Cleanrooms on Demand, enhancing its presence in the life sciences sector by leveraging Azzur's GxP manufacturing and testing services.
Target Information
Azzur Cleanrooms on Demand is recognized as a premier service provider in the life sciences sector, specializing in GxP (Good Practice) manufacturing and testing capacities. The company offers flexible cleanroom solutions tailored to the specific demands of its clients, facilitating high-quality production and testing environments in line with regulatory standards.
With a commitment to enhancing operational efficiency and ensuring compliance, Azzur has carved a niche in a market that increasingly relies on innovative and sustainable practices. Their expertise is further augmented by a deep understanding of the critical requirements in life sciences, positioning them as an essential partner for companies looking to streamline their manufacturing processes.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview
The life sciences industry is a vital component of the economy, particularly in regions focused on health care and pharmaceutical advancements. It encompasses all sectors involved in the research, development, production, and dis
Similar Deals
Bambu Ventures → Lemonaid Health
2026
Heartland Dental → Smile Design Dentistry
2025
Sun Pharmaceutical Industries Limited → Checkpoint Therapeutics, Inc.
2025
Court Square Capital and WindRose Health Investors → Soleo Health
2025
Patient Square Capital → Premier, Inc.
2025
Supernus Pharmaceuticals, Inc. → Sage Therapeutics, Inc.
2025
Chrysalis Holdings
invested in
Azzur Cleanrooms on Demand
in 2025
in a Buyout deal